Biopharma Money on the Move: October 21-27
The Pharma Data
OCTOBER 27, 2020
Sirnaomics is the only biopharma conducting R&D and clinical development in the field of RNAi therapeutics in both the U.S. million in 2015. Primmune’s early data shows the potential for PRTX007 to drive the natural innate immune response to combat systemic diseases. . In the U.S.,
Let's personalize your content